MedTrace Logo

Vascular Endothelial Factor Gene Polymorphism in Preeclampsia

NCT03500588 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2021-03-26

No results posted yet for this study

Summary

In this study, the investigators assessed one of the released protein factors during the pathophysiology of preeclampsia. They evaluated vascular endothelial growth factor gene mutation which affects the angiogenesis in case of inadequate placentation and its association with Doppler changes in the pulsatility index of the umbilical artery.

Conditions

Interventions

DIAGNOSTIC_TEST

PCR

Polymerase chain reaction was used to diagnose gene polymorphism.

DEVICE

Doppler ultrasound

Doppler ultrasound was used to assess the pulsatility index of the umbilical artery .

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2018-02-28

Countries

  • Egypt

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500588 on ClinicalTrials.gov